• İstanbul 19 °C
  • Ankara 23 °C

Pfizer, BioNTech seek vaccine approval in 6 regions

Pfizer, BioNTech seek vaccine approval in 6 regions
Firms to globally produce up to 50M doses in 2020, and up to 1.3B doses by end of 2021

By Ovunc Kutlu

ANKARA (AA) - Pfizer and BioNTech pharmaceutical firms announced Friday they have initiated submitting their COVID-19 vaccine candidate in six different regions in the world.

The companies said they will file their emergency use authorization request to the US Food and Drug Administration (FDA) on Friday, and their vaccine candidate will potentially be ready to be used in high-risk populations across the US by the middle to end of December 2020.

While the firms said they have already initiated rolling submissions in Australia, Canada, Europe, Japan and the UK for their vaccine, they also plan to submit applications immediately to other regulatory agencies around the world.

The companies said they expect to globally produce up to 50 million doses in 2020, and up to 1.3 billion doses by the end of 2021, as they will be ready to distribute the vaccine within hours after authorization.

The phase 3 trials of their vaccine started on July 27 on 43,661 global participants with 41,135 receiving a second dose on Nov. 8.

The companies announced on Nov. 9 their vaccine has an efficacy rate of more than 90%.


source: News Feed
This news is a total 60 time has been read
UYARI: Küfür, hakaret, rencide edici cümleler veya imalar, inançlara saldırı içeren, imla kuralları ile yazılmamış,
Türkçe karakter kullanılmayan ve büyük harflerle yazılmış yorumlar onaylanmamaktadır.
This news yet comment has been added .
Other News
All Rights Reserved © May 2014 US Muslims | Unauthorized and the resources published.
Haber Scripti: CM Bilişim